ImmunoPrecise Antibodies (IPA) Upgraded to Buy: What Does It Mean for the Stock?
ImmunoPrecise Antibodies (IPA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the companys earnings prospects.…
0,322€
24,81%
Echtzeit-Aktienkurs ImmunoPrecise Antibodies Ltd.
Bid:
Ask:
Nachrichten zur ImmunoPrecise Antibodies Ltd. Aktie
ImmunoPrecise Antibodies Ltd. (IPA) Q3 2025 Earnings Call Transcript
…
ImmunoPrecise Antibodies finance chief to step down
…
ImmunoPrecise Antibodies Ltd. (IPA) Q2 2025 Earnings Call Transcript
…
ImmunoPrecise Antibodies Ltd. (IPA) Q1 2025 Earnings Call Transcript
…
ImmunoPrecise Antibodies Ltd. (IPA) Reports Q1 Loss, Misses Revenue Estimates
ImmunoPrecise Antibodies (IPA) delivered earnings and revenue surprises of -22.22% and 22.44%, respectively, for the quarter ended July 2024. Do…
ImmunoPrecise Antibodies receives non-compliance notice from Nasdaq
…
ImmunoPrecise Antibodies Ltd. (IPA) Q4 2024 Earnings Call Transcript
…
ImmunoPrecise Antibodies Ltd. (IPA) Q3 2024 Earnings Call Transcript
…